Selective inhibition of the reverse transcription of duck hepatitis B virus by binding of 2′,3′-dideoxyguanosine 5′-triphosphate to the viral polymerase

Hepatology

Volumn 23, Issue 1, 1996, Pages 87-96

  Howe, Anita Yee Mei ^a   Robins, Morris Joseph ^b   Wilson, John Scott ^a   Tyrrell, David Lorne John ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Brigham Young University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2',3' DIDEOXYGUANOSINE TRIPHOSPHATE; DNA DIRECTED DNA POLYMERASE ALPHA; VIRUS DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA REPLICATION; DNA SYNTHESIS; DNA TEMPLATE; DUCK; ENZYME ACTIVITY; ENZYME BINDING; HEPATITIS B VIRUS; INHIBITION KINETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; REVERSE TRANSCRIPTION; VIRUS INHIBITION; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; BLOTTING, NORTHERN; BLOTTING, SOUTHERN; DEOXYGUANINE NUCLEOTIDES; DEPRESSION, CHEMICAL; DIDEOXYADENOSINE; DNA-DIRECTED DNA POLYMERASE; DUCKS; HEPATITIS B VIRUS, DUCK; RNA-DIRECTED DNA POLYMERASE; TRANSCRIPTION, GENETIC; VIRUS REPLICATION; ZALCITABINE;

EID: 0030034335     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510230113     Document Type: Article

References (24)

1. Sherlock S. Hepatitis B: the disease. Vaccine 1990;8(suppl):S6-S9.
2. Davis GL, Hoofnagle JH. Interferon in viral hepatitis: role in pathogenesis and treatment. HEPATOLOGY 1986;6:1038-1041.
3. Lai C-L, Lin HJ, Lau JYN, Flok AS, Wu PC, Chung HT, Wong LSK, et al. Effect of recombinant alpha 2 interferon with or without prednisone in Chinese HBsAg carrier children. Q J Med 1991;78:155-163.
4. Di Bisceglie AM, Rustgi VK, Kassianides C, Lisker-Melman M, Park Y, Waggoner JG, Hoofnagle JH. Therapy of chronic hepatitis B with recombinant human alpha and gamma interferon. HEPATOLOGY 1990;11:266-270.
5. Garcia G, Smith CI, Weissberg JI, Bissett J, Nair PV, Mastre B, Eisenberg M, et al. Adenine arabinoside monophosphate (vidarabine phosphate) in combination with human leukocyte interferon in the treatment of chronic hepatitis B. Ann Intern Med 1987;107:278-285.
6. Lee B, Luo W, Suzuki S, Robins MJ, Tyrrell DLJ. In vitro and in vivo comparison of the abilities of purine and pyrimidine 2′3′-dideoxynucleosides to inhibit duck hepadnavirus. Antimicrob Agents Chemother 1989;33:336-339.
7. Matthes E, Langen P, von Janta-Lipinski M, Will H, Schroder H, Merz HG, Weiler BE, et al. Potent inhibition of hepatitis B virus production in vitro by modified pyrimidine nucleosides. Antimicrob Agents Chemother 1990;34:1986-1990.
8. Kassianides C, Hoofnagle JH, Miller RH, Doo E, Ford H, Broder S, Mitsuya H. Inhibition of duck hepatitis B virus replication by 2′3′-dideoxycytidine. Gastroenterology 1989;97:1275-1280.
9. Löfgren B, Nordenfelt E, Öberg B. Inhibition of RNA- and DNA-dependent duck hepatitis B virus DNA polymerase activity by nucleoside and pyrophosphate analogs. Antiviral Res 1989;12:301-310.
10. Robinson WS. Hepadnaviridae and their replication. In: Fields BN, Knipe DM, eds. Virology. New York: Raven Press, 1990:2137-2169.
11. Blum HE, Gerok W, Vyas GN. The molecular biology of hepatitis B virus. TIG 1989;5:154-158.
12. Schödel F, Weimer T, Fernholz D, Schneider R, Sprengel R, Wildner G, Will H. The biology of avian hepatitis B viruses. In: McLachlan A, ed. Molecular biology of the hepatitis B virus. Boston: CRC Press, 1990:53-80.
13. Bartenschlager R, Schaller H. The amino-terminal domain of the hepadnaviral P-gene encodes the terminal protein (genome-linked protein) believed to prime reverse transcription. EMBO J 1988;7:4185-4192.
14. Wang GH, Seeger C. The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesis. Cell 1992;71:663-670.
15. Will H, Reiser W, Weimer T, Pfaff E, Büscher M, Sprengel R, Cattaneo R, et al. Replication strategy of human hepatitis B virus. J Virol 1987;61:904-911.
16. Hirsch RC, Loeb DD, Pollack JR, Ganem D. Cis-acting sequences required for encapsidation of duck hepatitis B virus pregenomic RNA. J Virol 1991;65:3309-3316.
17. Bartenschlager R, Schaller H. Hepadnaviral assembly is initiated by polymerase binding to the encapsidation signal in the viral RNA genome. EMBO J 1992;11:3413-3420.
18. Tavis JE, Perri S, Ganem D. Hepadnavirus reverse transcription initiates within the stem-loop of the RNA packaging signal and employs a novel strand transfer. J Virol 1994;68:3536-3543.
19. Wang G-H, Seeger C. Novel mechanism for reverse transcription in hepatitis B viruses. J Virol 1993;67:6507-6512.
20. Molnar-Kimber KL, Summers JW, Mason WS. Mapping of the cohesive overlap of duck hepatitis B virus DNA and of the site of initiation of reverse transcription. J Virol 1984;51:181-191.
21. Saldanha JA, Huang Q, Thomas HC, Monjardino J. Mapping of 5′ ends of virion-derived HBV DNA. Virology 1992;188:356-361.
22. Bartenschlager R, Junker-Niepmann M, Schaller H. The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation. J Virol 1990;64:5324-5332.
23. Blum HE, Galun E, Liang TJ, Weizsäcker F, Wands JR. Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication. J Virol 1991;65:1836-1842.
24. Suzuki S, Lee B, Luo W, Tovell D, Robins MJ, Tyrrell DLJ. Inhibition of duck hepatitis B virus replication by purine 2′3′-dideoxynucleosides. Biochem Biophys Res Commun 1988;156:1144-1151.